RU2012133434A - Способы и наборы для детекции факторов риска развития остеонекроза челюсти и способы его лечения - Google Patents
Способы и наборы для детекции факторов риска развития остеонекроза челюсти и способы его лечения Download PDFInfo
- Publication number
- RU2012133434A RU2012133434A RU2012133434/15A RU2012133434A RU2012133434A RU 2012133434 A RU2012133434 A RU 2012133434A RU 2012133434/15 A RU2012133434/15 A RU 2012133434/15A RU 2012133434 A RU2012133434 A RU 2012133434A RU 2012133434 A RU2012133434 A RU 2012133434A
- Authority
- RU
- Russia
- Prior art keywords
- bonj
- snp
- gene
- biomarker
- predisposition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Physical Education & Sports Medicine (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29273010P | 2010-01-06 | 2010-01-06 | |
| US61/292,730 | 2010-01-06 | ||
| PCT/US2010/060139 WO2011084387A2 (en) | 2010-01-06 | 2010-12-13 | Methods and kits for detecting risk factors for development of jaw osteonecrosis and methods of treatment thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2012133434A true RU2012133434A (ru) | 2014-02-27 |
Family
ID=44306025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012133434/15A RU2012133434A (ru) | 2010-01-06 | 2010-12-13 | Способы и наборы для детекции факторов риска развития остеонекроза челюсти и способы его лечения |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20130035314A1 (https=) |
| EP (1) | EP2521793A4 (https=) |
| CN (1) | CN102812132A (https=) |
| AU (1) | AU2010340161A1 (https=) |
| BR (1) | BR112012016744A2 (https=) |
| CA (1) | CA2786545A1 (https=) |
| IN (1) | IN2012DN06571A (https=) |
| RU (1) | RU2012133434A (https=) |
| WO (1) | WO2011084387A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010005939A1 (en) * | 2008-07-07 | 2010-01-14 | University Of Florida Research Foundation, Inc. | Methods and kits for detecting risk factors for development of jaw osteonecrosis and methods of treatment thereof |
| WO2015083163A1 (en) * | 2013-12-04 | 2015-06-11 | Micromedic Technologies Ltd. | Methods and kits for identifying susceptability to antiresorptive-agent-induced osteonecrosis of the jaw |
| CN111518882B (zh) * | 2019-02-03 | 2022-06-28 | 陈卫衡 | 通过分子标志物辨识激素性股骨头坏死的中医证型的系统 |
| CN112410413A (zh) * | 2020-09-24 | 2021-02-26 | 吉林大学 | Onfh易感相关vdr、mmp2、mmp3、mmp9基因snp的检测物质及应用 |
| ES2994026A1 (es) * | 2023-07-11 | 2025-01-16 | Fundacion Instituto De Investig Sanitaria De Santiago De Compostela | Metodo in vitro para identificar si un sujeto tratado con agentes modificadores de los huesos puede desarrollar osteonecrosis de los maxilares |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003062465A1 (es) * | 2002-01-25 | 2003-07-31 | Universidad De Barcelona | Compuestos para el diagnóstico de la predisposición a la osteoporosis |
| WO2010005939A1 (en) * | 2008-07-07 | 2010-01-14 | University Of Florida Research Foundation, Inc. | Methods and kits for detecting risk factors for development of jaw osteonecrosis and methods of treatment thereof |
-
2010
- 2010-12-13 EP EP10842489.6A patent/EP2521793A4/en not_active Withdrawn
- 2010-12-13 BR BR112012016744A patent/BR112012016744A2/pt not_active IP Right Cessation
- 2010-12-13 AU AU2010340161A patent/AU2010340161A1/en not_active Abandoned
- 2010-12-13 CN CN2010800648762A patent/CN102812132A/zh active Pending
- 2010-12-13 IN IN6571DEN2012 patent/IN2012DN06571A/en unknown
- 2010-12-13 WO PCT/US2010/060139 patent/WO2011084387A2/en not_active Ceased
- 2010-12-13 US US13/520,785 patent/US20130035314A1/en not_active Abandoned
- 2010-12-13 RU RU2012133434/15A patent/RU2012133434A/ru not_active Application Discontinuation
- 2010-12-13 CA CA2786545A patent/CA2786545A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2786545A1 (en) | 2011-07-14 |
| EP2521793A4 (en) | 2013-07-03 |
| AU2010340161A1 (en) | 2012-07-26 |
| US20130035314A1 (en) | 2013-02-07 |
| IN2012DN06571A (https=) | 2015-10-23 |
| EP2521793A2 (en) | 2012-11-14 |
| BR112012016744A2 (pt) | 2017-06-13 |
| WO2011084387A2 (en) | 2011-07-14 |
| WO2011084387A3 (en) | 2011-10-27 |
| CN102812132A (zh) | 2012-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Belote et al. | Human melanocyte development and melanoma dedifferentiation at single-cell resolution | |
| Lee et al. | Genome-scale profiling of gene expression in hepatocellular carcinoma: classification, survival prediction, and identification of therapeutic targets | |
| Herder et al. | The potential of novel biomarkers to improve risk prediction of type 2 diabetes | |
| Glocker et al. | Rheumatoid arthritis, a complex multifactorial disease: on the way toward individualized medicine | |
| US11312999B2 (en) | Set of genes for molecular classifying of medulloblastoma and use thereof | |
| JP2017079772A (ja) | 癌の分子的診断検査 | |
| US20150184248A1 (en) | Method for detecting pancreatic cancer and detection kit | |
| JP2022505295A (ja) | ヒト腫瘍のがん細胞における分子活性を定量化するための方法 | |
| RU2013141965A (ru) | Диагностика и лечение рака | |
| RU2012133434A (ru) | Способы и наборы для детекции факторов риска развития остеонекроза челюсти и способы его лечения | |
| CN109996893A (zh) | 鉴定心脏发育基因模式的表观基因组范围相关的研究和一类新的心力衰竭生物标记物 | |
| Caggiano et al. | Tissue informative cell-free DNA methylation sites in amyotrophic lateral sclerosis | |
| McNamara et al. | Circulating cell-free DNA methylation patterns indicate cellular sources of allograft injury after liver transplant | |
| Xu et al. | A functional+ 61G/A polymorphism in epidermal growth factor is associated with glioma risk among Asians | |
| Wang et al. | Identified OAS 3 gene variants associated with coexistence of HB sAg and anti‐HB s in chronic HBV infection | |
| WO2020021028A1 (en) | Biomarkers for the diagnosis and/or prognosis of frailty | |
| Fawaz et al. | Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research | |
| CN107653312B (zh) | 与血脂水平和冠心病相关的rs7901016检测系统及相关应用 | |
| CN108441560A (zh) | 一种位于cep128基因的与放疗引起的放射性脑损伤相关的snp标志物及其应用 | |
| CN107937515B (zh) | 一种阿尔茨海默的诊疗基因靶点及其应用 | |
| Sombekke et al. | Analysis of multiple candidate genes in association with phenotypes of multiple sclerosis | |
| Gonzalez-Rivera et al. | A cross-sectional comparison of druggable mutations in primary tumors, metastatic tissue, circulating tumor cells, and cell-free circulating DNA in patients with metastatic breast cancer: the MIRROR study protocol | |
| Fu et al. | Circulating cell-free DNA methylation profiles as noninvasive multiple sclerosis biomarkers: A proof-of-concept study | |
| CN108085381B (zh) | 一组基因突变位点在制备诊断慢性胰腺炎、评估预后的试剂或试剂盒中的应用 | |
| Seo et al. | Quality threshold evaluation of Sanger confirmation for results of whole exome sequencing in clinically diagnostic setting |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20150817 |